Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BSX Boston Scientific | ABT Abbott Laboratories |
|---|---|---|
| Price | $43.34 -0.5% | $102.61 +0.4% |
| StockIQ Score | 57C Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 13F | 19F |
| Fundamental | 75B+ | 72B |
| Growth | 79B+ | 45D+ |
| Fair Value | 62C+ | 38F |
| News | 86A | 100A+ |
| Quality | 63C+ | 63C+ |
| Risk | 54C- | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Boston Scientific outperforms Abbott Laboratories in growth and valuation, scoring 79 versus 45 in growth and 62 versus 38 in valuation. Both share a moderate rating, but Boston Scientific’s higher fundamental score (75 vs. 72) and technical score (47 vs. 50) give it a slight edge in overall stability and earnings strength. Abbott’s investor score is lower at 56 compared to Boston Scientific’s 64.